Virginia Laspidea

628 total citations
10 papers, 53 citations indexed

About

Virginia Laspidea is a scholar working on Genetics, Immunology and Oncology. According to data from OpenAlex, Virginia Laspidea has authored 10 papers receiving a total of 53 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 5 papers in Immunology and 4 papers in Oncology. Recurrent topics in Virginia Laspidea's work include Virus-based gene therapy research (6 papers), CAR-T cell therapy research (4 papers) and Cancer Research and Treatments (3 papers). Virginia Laspidea is often cited by papers focused on Virus-based gene therapy research (6 papers), CAR-T cell therapy research (4 papers) and Cancer Research and Treatments (3 papers). Virginia Laspidea collaborates with scholars based in Spain, United States and United Kingdom. Virginia Laspidea's co-authors include Marta M. Alonso, Sara Labiano, Marc García-Moure, Ana Patiño‐García, Zhihong Chen, Daniel de la Nava, Sandra Hervás‐Stubbs, Candelaria Gomez‐Manzano, Marisol González-Huarriz and Jaime Gállego Pérez‐Larraya and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Neuro-Oncology.

In The Last Decade

Virginia Laspidea

10 papers receiving 53 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Virginia Laspidea Spain	3	32	22	21	17	13	10	53
Daniel de la Nava Spain	5	39 1.2×	26 1.2×	34 1.6×	19 1.1×	15 1.2×	10	80
Marta Zalacain Spain	3	52 1.6×	48 2.2×	34 1.6×	15 0.9×	11 0.8×	3	73
Nathan Demars United States	4	27 0.8×	9 0.4×	11 0.5×	11 0.6×	14 1.1×	13	37
Reyes Acosta United States	2	20 0.6×	21 1.0×	71 3.4×	26 1.5×	15 1.2×	4	107
Maria G. Castro United States	5	15 0.5×	5 0.2×	22 1.0×	18 1.1×	26 2.0×	9	59
Nelli Frank Austria	4	25 0.8×	6 0.3×	30 1.4×	27 1.6×	17 1.3×	6	90
Luigi Barbarossa United Kingdom	3	22 0.7×	15 0.7×	25 1.2×	23 1.4×	5 0.4×	4	55
Takahiro Iguchi Japan	5	25 0.8×	19 0.9×	48 2.3×	41 2.4×	3 0.2×	5	95
Alexander Desuki Germany	6	35 1.1×	11 0.5×	36 1.7×	25 1.5×	5 0.4×	16	69
Erin E. Tapper United States	5	61 1.9×	11 0.5×	34 1.6×	13 0.8×	8 0.6×	13	75

Countries citing papers authored by Virginia Laspidea

Since Specialization

Citations

This map shows the geographic impact of Virginia Laspidea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginia Laspidea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginia Laspidea more than expected).

Fields of papers citing papers by Virginia Laspidea

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virginia Laspidea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginia Laspidea. The network helps show where Virginia Laspidea may publish in the future.

Co-authorship network of co-authors of Virginia Laspidea

This figure shows the co-authorship network connecting the top 25 collaborators of Virginia Laspidea. A scholar is included among the top collaborators of Virginia Laspidea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginia Laspidea. Virginia Laspidea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

García-Moure, Marc, Virginia Laspidea, Sumit Gupta, et al.. (2024). The emerging field of viroimmunotherapy for pediatric brain tumors. Neuro-Oncology. 26(11). 1981–1993. 2 indexed citations

Martínez-Vélez, Naiara, Daniel de la Nava, Noëlia Casares, et al.. (2024). Combination of locoregional radiotherapy with a TIM-3 aptamer improves survival in diffuse midline glioma models. JCI Insight. 9(18). 2 indexed citations

Fan, Xuejun, Sanjay K. Singh, Virginia Laspidea, et al.. (2023). IMMU-56. TARGETING NONO IN GLIOMA VIROIMMUNOTHERAPY. Neuro-Oncology. 25(Supplement_5). v155–v155. 1 indexed citations

Zalacain, Marta, Sara Labiano, Virginia Laspidea, et al.. (2022). Galectin-3 inhibition boosts the therapeutic efficacy of Semliki Forest virus in pediatric osteosarcoma. Molecular Therapy — Oncolytics. 26. 246–264. 6 indexed citations

Labiano, Sara, Daniel de la Nava, Marc García-Moure, et al.. (2022). DIPG-22. Modifying the tumor microenvironment with a TIM-3 monoclonal antibody as a therapeutic strategy for DIPGs. Neuro-Oncology. 24(Supplement_1). i22–i23. 1 indexed citations

Puigdelloses, Montse, Marc García-Moure, Sara Labiano, et al.. (2021). CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models. Journal for ImmunoTherapy of Cancer. 9(7). e002644–e002644. 31 indexed citations

Laspidea, Virginia, Sara Labiano, Daniel de la Nava, et al.. (2021). 745 Oncolytic adenovirus expressing 4-1BBL demonstrates a significant increase of survival in Diffuse Midline Glioma models. SHILAP Revista de lepidopterología. A776–A776. 2 indexed citations

Gupta, Sumit, Virginia Laspidea, Juàn Fueyo, et al.. (2021). Abstract 3053: Armed oncolytic virus for treatment of pediatric diffuse intrinsic pontine glioma. Cancer Research. 81(13_Supplement). 3053–3053. 1 indexed citations

Labiano, Sara, Virginia Laspidea, Marc García-Moure, et al.. (2021). 283 TIM-3 blockade modulates the tumor microenvironment improving the outcome of preclinical pediatric diffuse midline glioma models. Regular and Young Investigator Award Abstracts. A307–A307. 1 indexed citations

10.

Zalacaín, Marta, María Buñuales, Lucía Marrodán, et al.. (2020). Local administration of IL-12 with an HC vector results in local and metastatic tumor control in pediatric osteosarcoma. Molecular Therapy — Oncolytics. 20. 23–33. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact